ciprofloxacin has been researched along with Colonic Neoplasms in 14 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an in vitro study, the effect of ciprofloxacin was examined on proliferation of HT-29 human colon carcinoma cell line." | 7.69 | In vitro effect of ciprofloxacin on HT-29 human colon carcinoma cell line: assessment of cell proliferation by thymidine uptake and silver nucleolar organizer regions (AgNOR) histomorphometry. ( Dayan, D; Nyska, A; Rabau, M, 1995) |
| "In an in vitro study, the effect of ciprofloxacin was examined on proliferation of HT-29 human colon carcinoma cell line." | 3.69 | In vitro effect of ciprofloxacin on HT-29 human colon carcinoma cell line: assessment of cell proliferation by thymidine uptake and silver nucleolar organizer regions (AgNOR) histomorphometry. ( Dayan, D; Nyska, A; Rabau, M, 1995) |
| "In most of the patients studied, ambulatory conservative management was safe and effective in the treatment of uncomplicated acute diverticulitis." | 2.74 | [Safety and efficiency of ambulatory treatment of acute diverticulitis]. ( García Marín, A; Martín Gil, J; Pérez Díaz, MD; Rey Valcárcel, C; Sanz Sánchez, M; Serralta De Colsa, D; Turégano Fuentes, F; Vaquero Rodríguez, A, 2009) |
| "Acetaldehyde has been postulated to be a factor responsible for ethanol-associated carcinogenesis." | 1.31 | Microbially produced acetaldehyde from ethanol may increase the risk of colon cancer via folate deficiency. ( Homann, N; Salaspuro, M; Tillonen, J, 2000) |
| "Ciprofloxacin (200 mg) was administered iv, and intestinal samples were collected over a 120-min period." | 1.31 | Transepithelial intestinal excretion of ciprofloxacin in humans. ( Ben-Haim, M; Ramon, J; Rubinstein, E; Shabtai, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Kamal, A | 1 |
| Shaheer Malik, M | 1 |
| Bajee, S | 1 |
| Azeeza, S | 1 |
| Faazil, S | 1 |
| Ramakrishna, S | 1 |
| Naidu, VG | 1 |
| Vishnuwardhan, MV | 1 |
| Zhang, X | 1 |
| Chen, X | 1 |
| Guo, Y | 1 |
| Gao, G | 1 |
| Wang, D | 1 |
| Wu, Y | 1 |
| Liu, J | 1 |
| Liang, G | 1 |
| Zhao, Y | 1 |
| Wu, FG | 1 |
| Bykowska, A | 1 |
| Komarnicka, UK | 1 |
| Jeżowska-Bojczuk, M | 1 |
| Kyzioł, A | 1 |
| Jemel-Oualha, I | 1 |
| Elloumi-Mseddi, J | 1 |
| Beji, A | 1 |
| Hakim, B | 1 |
| Aifa, S | 1 |
| Martín Gil, J | 1 |
| Serralta De Colsa, D | 1 |
| García Marín, A | 1 |
| Vaquero Rodríguez, A | 1 |
| Rey Valcárcel, C | 1 |
| Pérez Díaz, MD | 1 |
| Sanz Sánchez, M | 1 |
| Turégano Fuentes, F | 1 |
| Crull, K | 1 |
| Weiss, S | 1 |
| Shi, ZY | 1 |
| Li, YQ | 1 |
| Kang, YH | 1 |
| Hu, GQ | 1 |
| Huang-fu, CS | 1 |
| Deng, JB | 1 |
| Liu, B | 1 |
| Herold, C | 2 |
| Ganslmayer, M | 2 |
| Ocker, M | 2 |
| Blauberger, S | 1 |
| Zopf, S | 1 |
| Hahn, EG | 2 |
| Schuppan, D | 2 |
| Hopf, G | 1 |
| Boecker, R | 1 |
| Benz, K | 1 |
| Stuetz, G | 1 |
| Viell, B | 1 |
| Vestweber, KH | 1 |
| Scholl, H | 1 |
| Schaaf, S | 1 |
| Rabau, M | 1 |
| Nyska, A | 1 |
| Dayan, D | 1 |
| Homann, N | 1 |
| Tillonen, J | 1 |
| Salaspuro, M | 1 |
| Ramon, J | 1 |
| Ben-Haim, M | 1 |
| Shabtai, M | 1 |
| Rubinstein, E | 1 |
| Gerauer, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Multicentric Controlled Clinical Trial of Parallel Groups to Evaluate the Non-therapeutic Inferiority of a Free Diet With a Progressive Diet, in the Treatment of Non-complicated Acute Diverticulitis[NCT03496090] | 134 participants (Actual) | Interventional | 2018-04-16 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ciprofloxacin and Colonic Neoplasms
| Article | Year |
|---|---|
[Safety and efficiency of ambulatory treatment of acute diverticulitis].
Topics: Abdominal Pain; Abscess; Acute Disease; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ambulatory C | 2009 |
13 other studies available for ciprofloxacin and Colonic Neoplasms
| Article | Year |
|---|---|
Synthesis and biological evaluation of conformationally flexible as well as restricted dimers of monastrol and related dihydropyrimidones.
Topics: Anti-Infective Agents; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; | 2011 |
Dual Gate-Controlled Therapeutics for Overcoming Bacterium-Induced Drug Resistance and Potentiating Cancer Immunotherapy.
Topics: Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Cell Line; Ciprofloxacin; Colonic N | 2021 |
Cu
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Apopt | 2018 |
Controversial effect on Erk activation of some cytotoxic drugs in human LOVO colon cancer cells.
Topics: Apoptosis; Blotting, Western; Cell Proliferation; Ciprofloxacin; Colonic Neoplasms; Enzyme Activatio | 2016 |
Antibiotic control of tumor-colonizing Salmonella enterica serovar Typhimurium.
Topics: Animals; Anti-Infective Agents; Carcinoma; Ciprofloxacin; Colonic Neoplasms; Disease Models, Animal; | 2011 |
Piperonal ciprofloxacin hydrazone induces growth arrest and apoptosis of human hepatocarcinoma SMMC-7721 cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell | 2012 |
Overadditive anti-proliferative and pro-apoptotic effects of a combination therapy on colorectal carcinoma cells.
Topics: Alitretinoin; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; | 2003 |
Concentration of ciprofloxacin and metronidazole in human tissues during abdominal surgery.
Topics: Anti-Infective Agents; Ciprofloxacin; Colonic Neoplasms; Humans; Infusions, Intravenous; Kinetics; M | 1989 |
A study of ciprofloxacin kinetics in human muscle and gut tissues.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Colon; Colonic Neoplasms; Humans; Intestinal Muco | 1989 |
In vitro effect of ciprofloxacin on HT-29 human colon carcinoma cell line: assessment of cell proliferation by thymidine uptake and silver nucleolar organizer regions (AgNOR) histomorphometry.
Topics: Carcinoma; Cell Division; Cell Survival; Ciprofloxacin; Colonic Neoplasms; Humans; Nucleolus Organiz | 1995 |
Microbially produced acetaldehyde from ethanol may increase the risk of colon cancer via folate deficiency.
Topics: Acetaldehyde; Animals; Anti-Infective Agents; Bacteria; Ciprofloxacin; Colon; Colonic Neoplasms; Ery | 2000 |
Transepithelial intestinal excretion of ciprofloxacin in humans.
Topics: Aged; Anti-Infective Agents; Cecum; Ciprofloxacin; Colonic Neoplasms; Female; Humans; Ileum; Intesti | 2001 |
Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells.
Topics: Anti-Infective Agents; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Division; Ciproflo | 2002 |